Maia Biotechnology Stock Analysis

MAIA
 Stock
  

USD 4.44  0.17  3.98%   

The current price rise of Maia Biotechnology may encourage investors to take a closer look at the firm as it is trading at a share price of 4.44 on 550,393 in trading volume. The company executives may have good odds in positioning the firm resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 17.89. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Maia Biotechnology partners.
Additionally, see Stocks Correlation.
  
The Maia Biotechnology stock analysis report makes it easy to digest most publicly released information about Maia Biotechnology and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Maia Biotechnology Stock analysis module also helps to analyze the Maia Biotechnology price relationship with some important fundamental indicators such as market cap and management efficiency.

Maia Biotechnology Stock Analysis Notes

About 45.0% of the company outstanding shares are owned by corporate insiders. The book value of Maia Biotechnology was now reported as 1.14. The company had not issued any dividends in recent years. MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. The company was founded in 2018 and is headquartered in Chicago, Illinois. Maia Biotechnology operates under Biotechnology classification in the United States and is traded on NYSEMKT Exchange. It employs 9 people. To find out more about Maia Biotechnology contact the company at 312 416 8592 or learn more at https://www.MAIABiotech.com.

Maia Biotechnology Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Maia Biotechnology's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Maia Biotechnology or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Maia Biotechnology is way too risky over 90 days horizon
Maia Biotechnology appears to be risky and price may revert if volatility continues
Maia Biotechnology has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (14.93 M).
Maia Biotechnology currently holds about 10.29 M in cash with (6.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29.
Roughly 45.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.bioworld.com: Financings for Aug. 3, 2022 - BioWorld Online

Management Efficiency

Maia Biotechnology management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 10th of August, Maia Biotechnology secures the mean deviation of 13.91, and Risk Adjusted Performance of 0.0731. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Maia Biotechnology, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Maia Biotechnology, which can be compared to its peers in the industry. Please verify Maia Biotechnology standard deviation, treynor ratio, downside variance, as well as the relationship between the information ratio and value at risk to decide if Maia Biotechnology is priced some-what accurately, providing market reflects its recent price of 4.44 per share. Given that Maia Biotechnology has jensen alpha of 0.9563, we recommend you to check Maia Biotechnology's last-minute market performance to make sure the company can sustain itself at a future point.

Maia Biotechnology Price Movement Analysis

The output start index for this execution was two with a total number of output elements of eight. The Simple Moving Average indicator is calculated by adding the closing price of Maia Biotechnology for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Maia Biotechnology short-term fluctuations and highlight longer-term trends or cycles.
.

Maia Biotechnology Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Maia Biotechnology insiders, such as employees or executives, is commonly permitted as long as it does not rely on Maia Biotechnology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Maia Biotechnology insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Maia Biotechnology Predictive Daily Indicators

Maia Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Maia Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Maia Biotechnology Forecast Models

Maia Biotechnology time-series forecasting models is one of many Maia Biotechnology's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Maia Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Maia Biotechnology Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Maia Biotechnology stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Maia Biotechnology shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Maia Biotechnology. By using and applying Maia Biotechnology Stock analysis, traders can create a robust methodology for identifying Maia Biotechnology entry and exit points for their positions.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Maia Biotechnology to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module
Additionally, see Stocks Correlation. Note that the Maia Biotechnology information on this page should be used as a complementary analysis to other Maia Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Maia Biotechnology Stock analysis

When running Maia Biotechnology price analysis, check to measure Maia Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maia Biotechnology is operating at the current time. Most of Maia Biotechnology's value examination focuses on studying past and present price action to predict the probability of Maia Biotechnology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Maia Biotechnology's price. Additionally, you may evaluate how the addition of Maia Biotechnology to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Maia Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maia Biotechnology. If investors know Maia Biotechnology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maia Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
45.2 M
The market value of Maia Biotechnology is measured differently than its book value, which is the value of Maia Biotechnology that is recorded on the company's balance sheet. Investors also form their own opinion of Maia Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Maia Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maia Biotechnology's market value can be influenced by many factors that don't directly affect Maia Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maia Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine Maia Biotechnology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maia Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.